Insufficient scRNA-seq data for expression of PCSK9 at single-cell level.
Insufficient scRNA-seq data for expression of PCSK9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4827.13 | 226 / 226 | 89% | 28.51 | 362 / 406 |
pancreas | 98% | 583.43 | 322 / 328 | 58% | 7.20 | 104 / 178 |
lung | 94% | 1292.65 | 544 / 578 | 57% | 15.15 | 658 / 1155 |
intestine | 44% | 514.68 | 429 / 966 | 87% | 38.39 | 461 / 527 |
esophagus | 42% | 351.14 | 611 / 1445 | 81% | 23.08 | 149 / 183 |
stomach | 32% | 193.97 | 115 / 359 | 77% | 25.45 | 220 / 286 |
tonsil | 0% | 0 | 0 / 0 | 93% | 33.71 | 42 / 45 |
skin | 67% | 213.83 | 1213 / 1809 | 7% | 1.40 | 35 / 472 |
uterus | 9% | 30.37 | 16 / 170 | 62% | 18.06 | 283 / 459 |
bladder | 0% | 0 | 0 / 21 | 41% | 13.59 | 208 / 504 |
peripheral blood | 32% | 154.07 | 299 / 929 | 0% | 0 | 0 / 0 |
spleen | 25% | 58.96 | 60 / 241 | 0% | 0 | 0 / 0 |
brain | 21% | 525.17 | 565 / 2642 | 0% | 0.01 | 1 / 705 |
adipose | 17% | 29.13 | 203 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 9% | 20.82 | 22 / 258 | 1% | 0.06 | 3 / 230 |
ovary | 5% | 8.97 | 9 / 180 | 4% | 0.61 | 17 / 430 |
breast | 4% | 9.21 | 18 / 459 | 4% | 0.53 | 45 / 1118 |
blood vessel | 7% | 12.76 | 97 / 1335 | 0% | 0 | 0 / 0 |
kidney | 7% | 8.93 | 6 / 89 | 0% | 0.02 | 2 / 901 |
prostate | 3% | 3.14 | 7 / 245 | 0% | 0.10 | 2 / 502 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
thymus | 0% | 0.36 | 2 / 653 | 0% | 0.05 | 2 / 605 |
muscle | 0% | 0.38 | 3 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.21 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1905596 | Biological process | negative regulation of low-density lipoprotein particle receptor binding |
GO_0010469 | Biological process | regulation of signaling receptor activity |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0007041 | Biological process | lysosomal transport |
GO_0010989 | Biological process | negative regulation of low-density lipoprotein particle clearance |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0016540 | Biological process | protein autoprocessing |
GO_0032802 | Biological process | low-density lipoprotein particle receptor catabolic process |
GO_0001822 | Biological process | kidney development |
GO_0001889 | Biological process | liver development |
GO_1905598 | Biological process | negative regulation of low-density lipoprotein receptor activity |
GO_0009267 | Biological process | cellular response to starvation |
GO_0042157 | Biological process | lipoprotein metabolic process |
GO_0002092 | Biological process | positive regulation of receptor internalization |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_0030182 | Biological process | neuron differentiation |
GO_0022008 | Biological process | neurogenesis |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0032805 | Biological process | positive regulation of low-density lipoprotein particle receptor catabolic process |
GO_0006915 | Biological process | apoptotic process |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0002091 | Biological process | negative regulation of receptor internalization |
GO_1905601 | Biological process | negative regulation of receptor-mediated endocytosis involved in cholesterol transport |
GO_0001920 | Biological process | negative regulation of receptor recycling |
GO_2000650 | Biological process | negative regulation of sodium ion transmembrane transporter activity |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_1990666 | Cellular component | PCSK9-LDLR complex |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_1990667 | Cellular component | PCSK9-AnxA2 complex |
GO_0031232 | Cellular component | extrinsic component of external side of plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005770 | Cellular component | late endosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0036020 | Cellular component | endolysosome membrane |
GO_0034190 | Molecular function | apolipoprotein receptor binding |
GO_0030547 | Molecular function | signaling receptor inhibitor activity |
GO_0034185 | Molecular function | apolipoprotein binding |
GO_0050750 | Molecular function | low-density lipoprotein particle receptor binding |
GO_0019871 | Molecular function | sodium channel inhibitor activity |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0003723 | Molecular function | RNA binding |
GO_0070326 | Molecular function | very-low-density lipoprotein particle receptor binding |
GO_0034189 | Molecular function | very-low-density lipoprotein particle binding |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | PCSK9 |
Protein name | Proprotein convertase subtilisin/kexin type 9 (Proprotein convertase 9) (Subtilisin/kexin-like protease PC9) Proprotein convertase subtilisin/kexin type 9 (EC 3.4.21.-) (Neural apoptosis-regulated convertase 1) (NARC-1) (Proprotein convertase 9) (PC9) (Subtilisin/kexin-like protease PC9) Proprotein convertase subtilisin/kexin type 9 |
Synonyms | PSEC0052 NARC1 |
Description | FUNCTION: Crucial player in the regulation of plasma cholesterol homeostasis. Binds to low-density lipid receptor family members: low density lipoprotein receptor (LDLR), very low density lipoprotein receptor (VLDLR), apolipoprotein E receptor (LRP1/APOER) and apolipoprotein receptor 2 (LRP8/APOER2), and promotes their degradation in intracellular acidic compartments . Acts via a non-proteolytic mechanism to enhance the degradation of the hepatic LDLR through a clathrin LDLRAP1/ARH-mediated pathway. May prevent the recycling of LDLR from endosomes to the cell surface or direct it to lysosomes for degradation. Can induce ubiquitination of LDLR leading to its subsequent degradation . Inhibits intracellular degradation of APOB via the autophagosome/lysosome pathway in a LDLR-independent manner. Involved in the disposal of non-acetylated intermediates of BACE1 in the early secretory pathway . Inhibits epithelial Na(+) channel (ENaC)-mediated Na(+) absorption by reducing ENaC surface expression primarily by increasing its proteasomal degradation. Regulates neuronal apoptosis via modulation of LRP8/APOER2 levels and related anti-apoptotic signaling pathways. . |
Accessions | A0A669KAY4 Q8NBP7 A0A669KB81 ENST00000302118.5 [Q8NBP7-1] ENST00000673903.1 A0A669KBG0 ENST00000673726.1 ENST00000673913.2 A0AA34QVH0 ENST00000710286.1 |